Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 121,235
  • Shares Outstanding, K 257,948
  • Annual Sales, $ 129,252 K
  • Annual Income, $ 1,645 K
  • 60-Month Beta 0.21
  • Price/Sales 1.81
  • Price/Cash Flow N/A
  • Price/Book 1.55
Trade LABS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.48
  • Most Recent Earnings -0.22 on 12/31/20
  • Next Earnings Date 03/31/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.02
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +84.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4450 +5.62%
on 03/26/21
0.5300 -11.32%
on 04/09/21
-0.0150 (-3.09%)
since 03/19/21
3-Month
0.4450 +5.62%
on 03/26/21
1.0000 -53.00%
on 02/10/21
-0.2600 (-35.62%)
since 01/20/21
52-Week
0.4450 +5.62%
on 03/26/21
2.2500 -79.11%
on 05/25/20
-1.4100 (-75.00%)
since 04/20/20

Most Recent Stories

More News
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical...

IMCC.CN : 6.690 (-5.77%)
IMCC : 5.30 (-3.28%)
LABS.TO : 0.4700 (unch)
MEDIF : 0.3690 (-1.34%)
Stocks in play: MediPharm Labs Corp.

Today announced it has exported its first shipment of cannabis oil products, approved by the Australian ...

LABS.TO : 0.4700 (unch)
Canada Jobs Due for Next Week

Monday U.S. Economic Lookahead Markit Services Purchasing Managers Index (final) (March) ...

ORMP : 8.34 (-1.42%)
SEAC : 1.0100 (-4.72%)
PAYX : 97.51 (+1.12%)
LNN : 160.76 (-1.58%)
GBX : 41.59 (-5.80%)
SGH : 52.61 (-4.92%)
RPM : 93.39 (+0.33%)
LW : 79.16 (-0.71%)
SMPL : 32.99 (-0.66%)
STZ : 238.31 (+0.30%)
LEVI : 28.91 (+2.26%)
C : 69.79 (-3.24%)
LABS.TO : 0.4700 (unch)
European Pharmaceutical Company STADA and MediPharm Labs Begin First Sales in Germany Under Exclusive Agreement

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm Labs") a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products,...

STDAF : 110.4200 (-3.98%)
LABS.TO : 0.4700 (unch)
MEDIF : 0.3690 (-1.34%)
Stocks in play: MediPharm Labs Corp.

Announced a further expansion of its innovative, pharma-quality family of branded products with the ...

LABS.TO : 0.4700 (unch)
Stocks in play: MediPharm Labs Corp.

Has entered into a supply agreement with the Société Quebecois Du Cannabis. MediPharm Labs will supply ...

LABS.TO : 0.4700 (unch)
Stocks in play: MediPharm Labs Corp.

Announced its wholly owned subsidiary, MediPharm Labs Australia Pty Ltd has entered into a new GMP white-label ...

LABS.TO : 0.4700 (unch)
Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.

Toronto, Ontario--(Newsfile Corp. - March 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE:TBF1) (the "" or ""), the leading innovator in cannabinoid and terpene blends in hard pill...

PILL.CN : 1.040 (+0.97%)
CTABF : 0.8219 (+0.65%)
LABS.TO : 0.4700 (unch)
MEDIF : 0.3690 (-1.34%)
Global CBD Based Skin Care Market Could Exceed $3.45 Billion By 2026

, /PRNewswire/ -- The personal care industry has witnessed a shift in consumer demand toward CBD infused skin & healthcare products over the past years and is expected to continue to grow for years to...

CANB : 0.5179 (+3.58%)
LABS.TO : 0.4700 (unch)
MEDIF : 0.3690 (-1.34%)
OGI : 2.34 (-10.00%)
OGI.TO : 2.94 (-10.09%)
TLRY : 15.89 (-8.89%)
CVSI : 0.4010 (-5.60%)
Stocks in play: MediPharm Labs Corp.

Announced Greg Hunter will join MediPharm Labs as Chief Financial Officer, effective February 8. MediPharm ...

LABS.TO : 0.4700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.4967
2nd Resistance Point 0.4833
1st Resistance Point 0.4767
Last Price 0.4700
1st Support Level 0.4567
2nd Support Level 0.4433
3rd Support Level 0.4367

See More

52-Week High 2.2500
Fibonacci 61.8% 1.5605
Fibonacci 50% 1.3475
Fibonacci 38.2% 1.1345
Last Price 0.4700
52-Week Low 0.4450

See More

Business Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar